Ilyang Pharmaceutical Co.,Ltd (007570.KS)
KRW 10880.0
(-2.07%)
KRW 10880.0
(-2.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 19.38 Billion | 29.93 Billion | 67.02 Billion | 57.48 Billion | 36.19 Billion | 22.12 Billion |
| Net Income | -2.5 Billion | 31.74 Billion | 25.95 Billion | 21.54 Billion | 19.59 Billion | 3.25 Billion |
| Depreciation & Amortization | 8.37 Billion | 13.06 Billion | 12.65 Billion | 12.66 Billion | 10.09 Billion | 12.01 Billion |
| Deferred income taxes | - | - | - | - | - | -675.93 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -11.9 Billion | -16.67 Billion | 16.35 Billion | 29.22 Billion | -1.67 Billion | -7.87 Billion |
| Other non-cash items | 25.41 Billion | 1.8 Billion | 12.06 Billion | -5.94 Billion | 8.18 Billion | 14.72 Billion |
| Investing Cash Flow | -62.6 Billion | 7.58 Billion | -21.34 Billion | -21.16 Billion | -1.21 Billion | -11.42 Billion |
| Investments in PPE | -12 Billion | -20.53 Billion | -21.35 Billion | -24.62 Billion | -8.38 Billion | -9.67 Billion |
| Acquisitions | 7.19 Million | 20 Million | 924 Thousand | 3.63 Billion | - | 8.13 Billion |
| Investment purchases | -21.35 Billion | -24.03 Billion | -565.4 Million | -617.09 Million | - | -2.17 Billion |
| Sales/Maturities of investments | 16.74 Billion | 52.15 Billion | -924 Thousand | 500 Million | 6.58 Billion | 997.91 Million |
| Other Investing Activities | -46 Billion | -13.99 Million | 573.63 Million | -57.72 Million | 588.41 Million | -8.7 Billion |
| Financing Cash Flow | -6.95 Billion | -23.39 Billion | -43.12 Billion | -30.96 Billion | -21.65 Billion | -11.53 Billion |
| Debt repayment | -308.76 Million | -63.15 Billion | -41.21 Billion | -25.41 Billion | -25.87 Billion | -32.07 Billion |
| Dividends payments | -3.87 Billion | -3.94 Billion | -8.77 Billion | -4.9 Billion | -5.81 Billion | -1.97 Billion |
| Common Stock Repurchased | -1.99 Billion | -3 Billion | - | - | - | - |
| Common Stock Issuance | -753.33 Million | - | - | - | - | - |
| Other Financing Activities | -22 Million | 46.7 Billion | 6.86 Billion | -647.43 Million | 10.03 Billion | 22.51 Billion |
| Accounts receivables | -4.18 Billion | 6.21 Billion | -2.55 Billion | 5.18 Billion | -7.64 Billion | 4.54 Billion |
| Accounts payables | -3.6 Billion | 8.94 Billion | -1.27 Billion | -1.74 Billion | 6.41 Billion | 2.31 Billion |
| Inventory | -4.77 Billion | -20.75 Billion | 7.67 Billion | 5.92 Billion | -3.79 Billion | 2.22 Billion |
| Other working capital | 653.18 Million | -11.07 Billion | 12.5 Billion | 19.85 Billion | 3.34 Billion | -10.1 Billion |
| Cash at beginning of period | 59.59 Billion | 47.73 Billion | 41.34 Billion | 35.89 Billion | 22.2 Billion | 23.55 Billion |
| Cash at end of period | 9.48 Billion | 59.59 Billion | 47.73 Billion | 41.34 Billion | 35.89 Billion | 22.2 Billion |
| Capital Expenditure | -12 Billion | -20.53 Billion | -21.35 Billion | -24.62 Billion | -8.38 Billion | -9.67 Billion |
| Effect of forex changes on cash | 115.33 Million | -2.26 Billion | 3.84 Billion | 82.48 Million | 364.86 Million | -509.99 Million |
| Net cash flow / Change in cash | -50.11 Billion | 11.86 Billion | 6.39 Billion | 5.44 Billion | 13.68 Billion | -1.34 Billion |
| Free Cash Flow | 7.37 Billion | 9.4 Billion | 45.66 Billion | 32.86 Billion | 27.8 Billion | 12.44 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.08 Billion | 2.02 Billion | -2.5 Billion | -7.37 Billion | 5.28 Billion | -2.08 Billion |
| Depreciation & Amortization | 1.74 Billion | 1.57 Billion | 8.37 Billion | 2.08 Billion | 3.39 Billion | 3.34 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 3.1 Billion | -1.38 Billion | -11.9 Billion | 6.89 Billion | -5.23 Billion | -1.92 Billion |
| Other non-cash items | 12.26 Billion | 9.06 Billion | 25.41 Billion | 8.94 Billion | 2.05 Billion | 3 Billion |
| Investing Cash Flow | -12.01 Billion | -2.91 Billion | -62.6 Billion | -8.25 Billion | -3.1 Billion | -1.39 Billion |
| Investments in PPE | -8.97 Billion | -4.99 Billion | -12 Billion | -4.98 Billion | -631.87 Million | -2.42 Billion |
| Acquisitions | - | - | 7.19 Million | 448.71 Thousand | 182.84 Million | -1.95 Billion |
| Investment purchases | -8.79 Billion | -7.24 Billion | -21.35 Billion | -7.01 Billion | -6.31 Billion | -3.77 Billion |
| Sales/Maturities of investments | 5.76 Billion | 9.26 Billion | 16.74 Billion | 3.74 Billion | 3.83 Billion | 4.86 Billion |
| Other Investing Activities | -1.8 Million | 60.18 Million | -46 Billion | - | -179.48 Million | 1.89 Billion |
| Financing Cash Flow | 2.76 Billion | 4.89 Billion | -6.95 Billion | -8.38 Billion | -3.38 Billion | 333.54 Million |
| Debt repayment | -5.93 Billion | -6.17 Billion | -308.76 Million | -8.19 Billion | -8.16 Billion | -3.91 Billion |
| Dividends payments | -2.78 Billion | -1.08 Billion | -3.87 Billion | -2.68 Million | -9.55 Million | -3.68 Billion |
| Common Stock Repurchased | - | - | -1.99 Billion | - | -357.26 Million | -1.64 Billion |
| Common Stock Issuance | - | - | -753.33 Million | - | 5.14 Billion | 1.64 Billion |
| Other Financing Activities | -192.57 Million | 4 Million | -22 Million | -193.16 Million | 3.1 Million | 7.93 Billion |
| Accounts receivables | -7.13 Billion | -81.28 Million | -4.18 Billion | 9.83 Billion | -17.8 Billion | -3.4 Billion |
| Accounts payables | 6.15 Billion | 2.12 Billion | -3.6 Billion | -10.58 Billion | 11.41 Billion | -1.63 Billion |
| Inventory | -6.85 Billion | -7.52 Billion | -4.77 Billion | 11.25 Billion | -1.16 Billion | -8.19 Billion |
| Other working capital | 10.94 Billion | 4.1 Billion | 653.18 Million | -3.61 Billion | 2.3 Billion | 11.3 Billion |
| Cash at beginning of period | 14.42 Billion | 9.48 Billion | 59.59 Billion | 9.35 Billion | 10.17 Billion | 9.25 Billion |
| Cash at end of period | 12.37 Billion | 14.42 Billion | 9.48 Billion | 9.48 Billion | 9.35 Billion | 10.17 Billion |
| Capital Expenditure | -8.97 Billion | -4.99 Billion | -12 Billion | -4.98 Billion | -631.87 Million | -2.42 Billion |
| Effect of forex changes on cash | - | 321.34 Million | 115.33 Million | -111.41 Million | 170.27 Million | -343.42 Million |
| Net cash flow / Change in cash | -2.05 Billion | 4.94 Billion | -50.11 Billion | 131.86 Million | -825.61 Million | 923.06 Million |
| Free Cash Flow | -2.11 Billion | -2.35 Billion | 7.37 Billion | 11.89 Billion | 4.86 Billion | -93.28 Million |
KINO
UD1U
IMC
CHZQ
ORTI-A
THES